Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Recent results in animal models of pancreatic carcinoma: histogenesis of tumors.

Longnecker DS, Memoli V, Pettengill OS.

Yale J Biol Med. 1992 Sep-Oct;65(5):457-64; discussion 465-9. Review.

2.
3.

K-ras and p53 mutations in hamster pancreatic ductal adenocarcinomas and cell lines.

Erill N, Cuatrecasas M, Sancho FJ, Farré A, Pour PM, Lluís F, Capellá G.

Am J Pathol. 1996 Oct;149(4):1333-9.

5.

Multiple genetic alterations in hamster pancreatic ductal adenocarcinomas.

Chang KW, Laconi S, Mangold KA, Hubchak S, Scarpelli DG.

Cancer Res. 1995 Jun 15;55(12):2560-8.

6.

Experimental pancreatic cancer: role of species, sex and diet.

Longnecker D.

Bull Cancer. 1990;77(1):27-37.

PMID:
2317574
7.

Determination of pancreatic ductal carcinoma histogenesis by analysis of mucous quality and K-ras mutation.

Matsubayashi H, Watanabe H, Nishikura K, Ajioka Y, Kijima H, Saito T.

Cancer. 1998 Feb 15;82(4):651-60.

PMID:
9477096
8.

Ductal origin of pancreatic adenocarcinomas induced by conditional activation of a human Ha-ras oncogene in rat pancreas.

Ueda S, Fukamachi K, Matsuoka Y, Takasuka N, Takeshita F, Naito A, Iigo M, Alexander DB, Moore MA, Saito I, Ochiya T, Tsuda H.

Carcinogenesis. 2006 Dec;27(12):2497-510. Epub 2006 Jun 13.

PMID:
16774944
9.

The mutant K-ras oncogene causes pancreatic periductal lymphocytic infiltration and gastric mucous neck cell hyperplasia in transgenic mice.

Brembeck FH, Schreiber FS, Deramaudt TB, Craig L, Rhoades B, Swain G, Grippo P, Stoffers DA, Silberg DG, Rustgi AK.

Cancer Res. 2003 May 1;63(9):2005-9.

11.

Acinar-to-ductal metaplasia accompanies c-myc-induced exocrine pancreatic cancer progression in transgenic rodents.

Grippo PJ, Sandgren EP.

Int J Cancer. 2012 Sep 1;131(5):1243-8. doi: 10.1002/ijc.27322. Epub 2012 Jan 11.

12.

K-ras oncogene mutations in osteoclast-like giant cell tumors of the pancreas and liver: genetic evidence to support origin from the duct epithelium.

Westra WH, Sturm P, Drillenburg P, Choti MA, Klimstra DS, Albores-Saavedra J, Montag A, Offerhaus GJ, Hruban RH.

Am J Surg Pathol. 1998 Oct;22(10):1247-54. Review.

PMID:
9777987
13.

Colloid (mucinous noncystic) carcinoma of the pancreas.

Adsay NV, Pierson C, Sarkar F, Abrams J, Weaver D, Conlon KC, Brennan MF, Klimstra DS.

Am J Surg Pathol. 2001 Jan;25(1):26-42.

PMID:
11145249
14.

Molecular and immunochemical analyses of RB1 and cyclin D1 in human ductal pancreatic carcinomas and cell lines.

Huang L, Lang D, Geradts J, Obara T, Klein-Szanto AJ, Lynch HT, Ruggeri BA.

Mol Carcinog. 1996 Feb;15(2):85-95.

PMID:
8599583
15.

Malignant transformation of duct-like cells originating from acini in transforming growth factor transgenic mice.

Wagner M, Lührs H, Klöppel G, Adler G, Schmid RM.

Gastroenterology. 1998 Nov;115(5):1254-62.

PMID:
9797382
16.

Preinvasive duct-derived neoplasms in pancreas of keratin 5-promoter cyclooxygenase-2 transgenic mice.

Müller-Decker K, Fürstenberger G, Annan N, Kucher D, Pohl-Arnold A, Steinbauer B, Esposito I, Chiblak S, Friess H, Schirmacher P, Berger I.

Gastroenterology. 2006 Jun;130(7):2165-78.

PMID:
16762637
17.

A rat model of pancreatic ductal adenocarcinoma: targeting chemical carcinogens.

Rivera JA, Graeme-Cook F, Werner J, Z'graggen K, Rustgi AK, Rattner DW, Warshaw AL, Fernández-del Castillo C.

Surgery. 1997 Jul;122(1):82-90.

PMID:
9225919
18.

Animal models of exocrine pancreatic carcinogenesis.

Rao MS.

Cancer Metastasis Rev. 1987;6(4):665-76. Review.

PMID:
3127071
19.

Genomic p53 mutation in a chemically induced hamster pancreatic ductal adenocarcinoma.

Chang KW, Mangold KA, Hubchak S, Laconi S, Scarpelli DG.

Cancer Res. 1994 Jul 15;54(14):3878-83.

20.

Supplemental Content

Support Center